Sulfur-containing xanthine derivatives as adenosine antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544267, 544268, C07D47306, A61K 3152

Patent

active

054534267

ABSTRACT:
The present invention provides sulfur-containing xanthine derivatives which are 1,3-disubstituted with a C.sub.1 -C.sub.12 alkyl, which may be further substituted with a hydroxy, amino, or halo group, and are 8-substituted with either a cycloalkyl, furyl, thienyl, or substituted phenyl group. These derivatives possess increased selectivity or potency at adenosine receptors.

REFERENCES:
patent: 4546182 (1985-10-01), Kjellin et al.
patent: 4564182 (1985-10-01), Kjellin et al.
patent: 4820709 (1989-04-01), Hofer
patent: 4879296 (1989-11-01), Daluge
patent: 4925847 (1990-05-01), Hofer
Chemical Abstracts vol. 111:77745(g) 1989.
Chemical Abstracts vol. 98 1252(z) (1983).
Chemical Abstracts vol. 98 125211z (1983).
Chemical Abstracts vol. 106 67009K (1987).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Sulfur-containing xanthine derivatives as adenosine antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sulfur-containing xanthine derivatives as adenosine antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfur-containing xanthine derivatives as adenosine antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1551975

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.